Summary
Effects of a single dose of 200 IU of nasal salmon calcitonin (SCT) on calcium metabolism and biochemical markers of bone turnover were investigated in 12 healthy male volunteers in a randomized, placebo-controlled, crossover design. The nasal spray was given in the morning, and subsequently blood and urine samples were collected for 26 hours. There was a significant decrease in serum ionized calcium with a nadir 4 hours after administration of nasal SCT accompanied by a significant increase in serum parathyroid hormone (P = 0.01) and serum calcitriol (P = 0.04). Nasal SCT did not reduce urinary hydroxyproline/creatinine. Urinary deoxypyridinoline/creatinine was lowered significantly 2 hours after administration of nasal SCT and throughout the first 24 hours, but remained unchanged for the last 2 hours. On a 24-hour basis, urinary deoxypyridinoline/creatinine decreased from 14.1 (3.5) nmol/mmol to 11.7 (3.2) nmol/mmol after nasal SCT (P = 0.04). Nasal SCT did not change the serum levels of alkaline phosphatase, osteocalcin, and the carboxyterminal propeptide of type 1 procollagen. The results indicate that nasal SCT given as a single dose provokes a modest decrease in bone resorption lasting several hours, but leaves bone formation unaffected.
Similar content being viewed by others
References
Krane SM, Harris ED, Singer FR, Potts JT (1973) Acute effects of calcitonin on bone formation in man. Metabolism 22:51–58
Riggs BL, Arnaud CD, Goldsmith RS, Taylor WF, McCall JT, Sessler SD (1971) Plasma kinetics and acute effects of pharmacologic doses of porcine calcitonin in man. J Clin Endocrinol 33:115–127
Simon LS, Krane SM, Wortman PD, Krane IM, Kovitz KL (1984) Serum levels of type I and 111 procollagen fragments in Paget's disease of bone. J Clin Endocrinol Metab 58:110–120
Gonzalez D, Ghiringhelli G, Mautalen C (1986) Acute antiosteoclastic effect of salmon calcitonin in osteoporotic women. Calcif Tissue Int 38:71–75
Martin TJ, Melick RA (1969) The acute effects of porcine calcitonin in man. Aus Ann Med 18:258–263
Bijvoet OLM, van der Sluys Veer J, Jansen AP (1968) Effects of calcitonin on patients with Paget's disease, thyrotoxicosis or hypercalcaemia. Lancet i:876–881
Stone MD, Marshall DH, Hosking DJ, Garcia-Himmelstine C, White DA, Worth HG (1992) Comparison of low-dose intramuscular and intravenous calcitonin in the treatment of primary hyperparathyroidism. Bone 13:265–271
Gonzales D, Vega E, Ghiringhelli G, Mautalen C (1987) Comparison of the acute effect of the intranasal and intramuscular administration of salmon calcitonin in Paget's disease. Calcif Tissue Int 41:313–315
Buclin T, Randin JP, Jacquet AF, Azria M, Attinger M, Gomez F, Burckhardt P (1987) The effect of rectal and nasal administration of salmon calcitonin in normal subjects. Calcif Tissue Int 41:252–258
Kivirikko KI, Laitinen O, Prockop DJ (1967) Modifications of a specific assay for hydroxyproline in urine. Anal Biochem 19:249–255
Eyre DR, Koob TJ, Van Ness KP (1984) Quantitation of hydroxypyridinium crosslinks in collagen by high-performance liquid chromatography. Anal Biochem 137:380–388
Black D, Duncan A, Robins SP (1988) Quantitative analysis of the pyridinium crosslinks in urine using ion-paired reversedphase high-performance liquid chromatography. Anal Biochem 169:197–203
Kollerup G, Thamsborg G, Bathia H, Sorensen OH (1992) Quantitation of urinary hydroxypyridium cross-links in collagen by high-performance liquid chromatography. Scand J Clin Lab Invest 52:657–662
Hyldstrup L, Clemmensen I, Jensen BA, Transbøll I (1988) Non-invasive evaluation of bone formation: measurements of serum alkaline phosphatase, whole body retention of diphosphonate and serum osteocalcin in metabolic bone disorders and thyroid disease. Scand J Clin Lab Invest 48:611–619
Melkko J, Niemi S, Risteli L, Risteli J (1990) Radioimmunoassay of the carboxyterminal propeptide of human type I procollagen. Clin Chem 36:1328–1332
Thamsborg G, Storm TL, Daugaard H, Schifter S, Sorensen OH (1991) Circulating levels of calciotropic hormones during treatment with nasal salmon calcitonin Acta Endocrinol (Copenh) 125:127–131
Reginster JY, Denis D, Albert A, Franchimont P (1987) Assessment of the biological effectiveness of nasal synthetic salmon calcitonin (SSCT) by comparison with intramuscular (i.m.) or placebo injection in normal subjects. Bone Miner 2:133–140
Pontiroli AE, Alberetto M, Pozza G (1985) Intranasal calcitonin and plasma calcium concentrations in normal subjects. Br Med J 290:1390–1391
Gennari C, Chierichetti SM, Vibelli C, Francini G, Maioli E, Gonnelli S (1981) Acute effects of salmon, human and porcine calcitonin on plasma calcium and cyclic AMP levels in man. Curr Ther Res 30:1024–1032
Markowitz M, Rotkin L, Rosen JF (1981) Circadian rhythms of blood minerals in human. Science 312:672–674
Kawashima H, Torikai S, Kurokawa K (1987) Calcitonin selectively stimulates 25-hydroxyvitamin D3-lalfa-hydroxylase in proximal tubule of rat kidney. Nature 291:327–329
Galante L, Colston KW, MacAuley SJ, MacIntyre I (1972) Effect of calcitonin on vitamin D metabolism. Nature 238:271–273
Jaeger P, Jones W, Clemens TL, Hayslett JP (1986) Evidence that calcitonin stimulates 1,25-dihydroxyvitamin D production and intestinal absorption of calcium in vivo. J Clin Invest 78:451–461
Emmertsen K, Melsen F, Mosekilde L, Lund Bi, Lund Bj, Sørensen OH, Nielsen HE, Sølling H, Hansen H (1981) Altered vitamin D metabolism and bone remodeling in patients with thyroid carcinoma and hypercalcitoninemia. Metab Bone Dis Rel Res 4:17–23
Charles P, Poser JW, Mosekilde L, Jensen FT (1985) Estimation of bone turnover evaluated by47Ca-kinetics. J Clin Invest 76:2254–2258
Klein L, Lafferty FW, Pearson OH, Curtiss PH (1964) Correlation of urinary hydroxyproline, serum alkaline phosphatase and skeletal calcium turnover. Metabolism 13:272–283
Estell R, Hampton L, Colwell A, Green JR, Assiri AMA, Hesp R, Russell RGG, Reeve J (1990) Urinary collagen crosslinks are highly correlated with radioisotopic measurements of bone re sorption. In: Christiansen C, Overgard K (eds) Osteoporosis 1990. Osteopress Aps, Copenhagen, pp 469–470
Delmas PD, Schlemmer A, Gineyts E, Riis B, Christiansen C (1991) Urinary excretion of pyridinoline crosslinks correlates with bone turnover measured on iliac crest biopsy in patients with vertebral osteoporosis. J Bone Miner Res 6:639–644
Delmas PD, Malaval L, Arlot ME, Meunier PJ (1985) Serum bone gla-protein compared to bone histomorphometry in endocrine diseases. Bone 6:339–341
Risteli J, Melkko J, Niemi S, Risteli L (1991) Use of a marker of collagen formation in osteoporosis studies. Calcif Tissue Int (suppl) 49:S24-S25
Thamsborg G, Storm TL, Brinch E, Sykulski R, Fogh-Andersen N, Sorensen OH (1990) The effect of different doses of nasal salmon calcitonin on plasma cyclic AMP and serum ionized calcium. Calcif Tissue Int 46:5–8
Lewitt M, McDowall D, Clifton-Bligh P, Marel G, Hooper MJ (1987) The effect of nasal administration of synthetic salmon calcitonin. In: Christiansen C, Johansen JS, Riis BJ (eds) Osteoporosis 1987. Osteopress Aps, Copenhagen, pp 925–927
Schlemmer A, Hassager C, Jensen SB, Christiansen C (1992) Marked diurnal variation in urinary excretion of pyridinium cross-links in premenopausal women. J Clin Endocrinol Metab 74:476–180
Tilyard MW, Spears GFS, Thomson J, Dovey S (1992) Treatment of postmenopausal osteoporosis with calcitriol or calcium. N Engl J Med 326:357–362
Reeve J, Meunier PJ, Parsons JA, Bernat M, Bijvoet OLM, Courpron P, Edouard C, Klenerman L, Neer RM, Renier JC, Slovik D, Vismans FIFE, Potss JT (1980) Anabolic effect of human parathyroid hormone fragment on trabecular bone in involutional osteoporosis: a multicentre trial. Br Med J 280:1340–1344
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Thamsborg, G., Skousgaard, S.G., Daugaard, H. et al. Acute effects of nasal salmon calcitonin on calcium and bone metabolism. Calcif Tissue Int 53, 232–236 (1993). https://doi.org/10.1007/BF01320907
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF01320907